Iopofosine I 131 single dose

Drug identity checked against registry records

Also recorded as CLR 131; I-131-CLR1404

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in WaldenstromNCT02952508CLRBPhase 2Active not recruiting2026-06-22Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.